Comment on

• Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

  Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators. Scirica BM, et al. N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992601 Clinical Trial.
• Saxagliptin, alogliptin, and cardiovascular outcomes.

  Standl E. Standl E. N Engl J Med. 2014 Jan 30;370(5):483. doi: 10.1056/NEJMc1313880. N Engl J Med. 2014. PMID: 24476445 No abstract available.